Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates
AUTOR(ES)
Brandolt, Tchana Martinez, Klafke, Gabriel Baracy, Gonçalves, Carla Vitola, Bitencourt, Laura Riffel, Martinez, Ana Maria Barral de, Mendes, Josiara Furtado, Meireles, Mário Carlos Araújo, Xavier, Melissa Orzechowski
FONTE
Braz. J. Microbiol.
DATA DE PUBLICAÇÃO
2017-03
RESUMO
Abstract Vulvovaginal candidiasis (VVC) is an infection of the genital mucosa caused by different species of the genus Candida. Considering the lack of data on this topic in the south of Brazil, this study aimed to assess the prevalence of Candida spp. in the cervical-vaginal mucosa of patients treated at a university hospital in southern Rio Grande do Sul, as well as the etiology and the susceptibility of the isolates against fluconazole, itraconazole, miconazole and nystatin. Samples were collected at the gynecology clinic of the Federal Hospital of the University of Rio Grande, and the isolates were identified using phenotypic and biochemical tests. The susceptibility analysis was performed according to the CLSI M27-A2 protocol. Of the 263 patients included, Candida spp. was isolated in 27%, corresponding to a prevalence of approximately 15% for both VVC and colonization. More than 60% of the isolates were identified as Candida albicans; C. non-albicans was isolated at a rate of 8.6% in symptomatic patients and 14.3% in asymptomatic patients. The prevalence of resistance against fluconazole and itraconazole was 42% and 48%, respectively; the minimal inhibitory concentration of miconazole ranged from 0.031 to 8 µg/mL, and that of nystatin ranged from 2 to >16 µg/mL. The high rate of resistance to triazoles observed in our study suggests the necessity of the association of laboratory exams to clinical diagnosis to minimize the practice of empirical treatments that can contribute to the development of resistance in the isolates.
Documentos Relacionados
- Frequency of Trichomonas vaginalis, Candida sp and Gardnerella vaginalis in cervical-vaginal smears in four different decades
- In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals
- Prevalence and Fluconazole Susceptibility Profile of Candida spp. Clinical Isolates in a Brazilian Tertiary Hospital in Minas Gerais, Brazil
- Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals
- Azasordarins: Susceptibility of Fluconazole-Susceptible and Fluconazole-Resistant Clinical Isolates of Candida spp. to GW 471558